Increased Oversight of Dangerous Pathogen Sales and High-Risk Laboratories.
This law establishes strict new rules for selling highly infectious agents, requiring sellers to maintain electronic logbooks and verify buyer identity and intended use. It also mandates regular security evaluations of high-containment laboratories across the US to enhance public health protection and prevent the misuse of dangerous biological materials. These measures directly increase public safety by reducing the risk of accidental release or malicious use of dangerous pathogens.
Key points
Mandatory electronic logbooks for all sales of highly infectious agents (Risk Group 3 or 4 pathogens).
Buyers must present photo ID and state the intended use; providing false information is subject to criminal penalties.
Implementation of periodic strategic evaluations and national standards for the security and operation of high-containment laboratories (BSL-3 and BSL-4).
Expired
Citizen Poll